- Home
- CLMT vs PRCT Comparison
CLMT vs PRCT Comparison
Compare CLMT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLMT | PRCT |
|---|---|---|
| Founded | 1916 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLMT | PRCT |
|---|---|---|
| Price | $20.25 | $30.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $20.45 | ★ $51.13 |
| AVG Volume (30 Days) | 933.9K | ★ 1.1M |
| Earning Date | 02-27-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,048,000,000.00 | $299,907,000.00 |
| Revenue This Year | $0.23 | $48.30 |
| Revenue Next Year | $3.14 | $29.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 50.07 |
| 52 Week Low | $7.68 | $27.80 |
| 52 Week High | $22.10 | $79.29 |
Technical Indicators
Market Signals| Indicator | CLMT | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 59.10 | 41.81 |
| Support Level | $19.29 | $29.62 |
| Resistance Level | $21.27 | $35.20 |
| Average True Range (ATR) | 0.75 | 1.60 |
| MACD | 0.05 | -0.29 |
| Stochastic Oscillator | 69.79 | 15.92 |
Price Performance
Historical ComparisonAbout CLMT Calumet Specialty Products Partners L.P.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.